Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05860959 · ClinicalTrials.gov registry record
SUBLOCADE Long-term Outcomes
A clinical trial, sponsored by Indivior.
- Completed
- Registry status
- 480
- Enrollment target
NCT05860959 is a clinical trial that has completed, run by Indivior. The registered enrollment target is 480 participants.
The verdict
NCT05860959 has completed, sponsored by Indivior.
- COMPLETED
- Registry status
- 480 participants
- Enrollment target
Study Summary
This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as measures of participants' physical, psychological, social, and economic well-being will be monitored to better understand factors associated with recovery from opioid use disorder (OUD). Therefore, this study will observe participants up to a maximum of 4 years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2023-08-31 |
| Est. Completion | 2025-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05860959
The ClinicalTrials.gov registry entry for NCT05860959 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indivior, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05860959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05860959 about?
NCT05860959 is a clinical study titled "SUBLOCADE Long-term Outcomes". This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as ...
What is the current status of trial NCT05860959?
This trial is currently completed. The enrollment target is 480 participants. The study started on 2023-08-31. Estimated completion is 2025-08-31.
Who is sponsoring clinical trial NCT05860959?
This trial is sponsored by Indivior, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.